Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 2Carcinoma, Non-Small-Cell Lung 2Solid Tumors 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Advanced Malignant Neoplasm 1

Interventions

Paclitaxel 2Oxaliplatin 2Leucovorin 2Irinotecan 2Fluorouracil 2Capecitabine 2nimotuzumab 1lenvatinib 1fludarabine 1cat's claw extract 1TH 302 1Interleukin-2 1Injections 1Infusions, Intravenous 1Gemcitabine 1Drug Evaluation 1Cyclophosphamide 1Carboplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Solid Tumors × Infusions, Intravenous × Clear all
NCT05524194 2022-09-01

6MW3511 in Patients With Advanced Solid Tumor

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 1/2 Unknown
272 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡